Table 1.

Numbers of both genes QMSP positive cases in the main tumor

Number	DCC	EDNRB	HOXA9	KIF1A	NID2	NR2B
DCC	***	44 (67.7%)	50 (76.9%)	27 (41.5%)	53 (81.5%)	31 (47.7%)
EDNRB	39 (61.9%)	***	43 (66.2%)	24 (36.9%)	45 (69.2%)	26 (40.0%)
HOXA9	48 (76.2%)	41 (65.1%)	***	27 (41.5%)	56 (86.2%)	30 (46.2%)
KIF1A	39 (61.9%)	33 (52.4%)	42 (66.7%)	***	29 (44.6%)	18 (27.7%)
NID2	48 (76.2%)	41 (65.1%)	52 (82.5%)	40 (63.5%)	***	32 (49.2%)
NR2B	27 (42.9%)	23 (36.5%)	32 (50.8%)	23 (36.5%)	30 (47.6%)	***

Number of cases with concomitantly positive QMSP for two genes among each imprint cohort (n=65, upper left white area) and tissue cohort (n=63, lower right grey area) were listed. Coverage percentage was calculated as a ratio of the number of the cases with a both positive main tumor to the total number of each cohort.